What Chemicals Regulate the Cell Cycle: Cyclins & CDKs

The cell cycle is regulated by a coordinated set of proteins, with cyclins and cyclin-dependent kinases (CDKs) serving as the central drivers. These two protein families work together as paired complexes, rising and falling in concentration at precise times to push a cell through each phase of division. But they don’t act alone. A wider network of growth signals, braking proteins, damage sensors, and protein-destruction machinery all feed into the system, creating a tightly controlled sequence that determines when a cell divides and when it stays put.

Cyclins and CDKs: The Core Engine

CDKs are enzymes that are always present in the cell but remain inactive on their own. They only switch on when they bind to a partner protein called a cyclin. Different cyclins appear at different times during the cell cycle, and each one pairs with a specific CDK to drive a particular phase forward. Think of CDKs as engines that need a key to start: the cyclin is that key, and the cell builds and destroys different keys at different moments.

Four main cyclins handle the job. In early G1 (the first growth phase), cyclin D pairs with CDK4 and CDK6 to get things moving. In late G1, cyclin E partners with CDK2 to push the cell toward DNA replication. During S phase, when DNA is actually being copied, cyclin A takes over with CDK2. Then in late S phase and G2, cyclin A switches to CDK1. Finally, cyclin B binds CDK1 to drive the cell into and through mitosis, the physical splitting stage. Each pairing activates the kinase, which then attaches phosphate groups to target proteins, changing their behavior and advancing the cycle.

The system’s elegance lies in timing. Cyclin levels don’t stay constant. They build up when needed and are rapidly destroyed afterward, ensuring each phase happens once and in the correct order.

Growth Factors That Start the Process

Before any of the cyclin-CDK machinery kicks in, a cell typically needs an external green light. Cells sitting in a resting state (called G0) won’t enter the cycle unless they receive chemical signals from outside, most commonly growth factors, also called mitogens.

When a growth factor binds to a receptor on the cell surface, it triggers internal signaling cascades. Two of the most important are the MAPK pathway (Ras/Raf/MEK/ERK) and the PI3K/AKT/mTOR pathway. The MAPK pathway dominates early G1, activating transcription factors that turn on genes for cyclin D and other growth-related proteins. The PI3K/AKT/mTOR pathway picks up in late G1, helping the cell assess whether it has enough resources to commit to division. Other signaling routes, including the Hippo and Wnt pathways activated by physical contact between cells, also feed into the decision. The key point is that without these upstream chemical signals, the cyclin-CDK engine never fires up.

Hormones and Tissue-Specific Signals

In hormone-responsive tissues like breast tissue, steroid hormones act as powerful regulators of the cell cycle. Estrogen drives cells into division by boosting levels of cyclin D1 and a growth-promoting gene called c-myc. It also encourages formation of active cyclin E-CDK2 complexes while stripping away certain braking proteins, effectively removing obstacles to S phase entry.

Progesterone has a more complex role. Initially it can stimulate division through similar cyclin targets, but over time it slows things down by reducing cyclin D1 and cyclin E levels and recruiting CDK inhibitors into the active complexes. This delayed braking effect is tied to progesterone’s role in pushing cells toward differentiation rather than continued proliferation. Both hormones ultimately work by adjusting the same core machinery (cyclin abundance and CDK inhibitor recruitment) rather than using a separate system.

The Braking System: CDK Inhibitors

Equally important as the proteins that drive division are the ones that stop it. Cells produce a family of small proteins called CDK inhibitors (CKIs) that bind directly to cyclin-CDK complexes and shut them down. These fall into two groups with different targets.

  • INK4 family (p15, p16): These specifically block CDK4 and CDK6, the kinases active in early G1. By locking onto these CDKs, they prevent cyclin D from activating them, which stalls the cell before it commits to division. Both function as tumor suppressors.
  • Cip/Kip family (p21, p27): These have broader reach. p21 can inhibit CDK1, CDK2, and CDK4, making it a versatile brake across multiple phases. p27 primarily targets CDK2 and CDK4, playing a crucial role at the G1-to-S transition. Interestingly, Cip/Kip family members also help assemble cyclin D-CDK4/6 complexes in early G1, so they play a dual role: facilitating one complex while inhibiting others.

The balance between active cyclin-CDK complexes and CKI levels is what determines whether a cell moves forward or stops. When inhibitors outweigh the active complexes, the cell arrests.

The p53-Rb Checkpoint Pathway

Two of the most important tumor suppressor proteins, p53 and Rb (retinoblastoma protein), form a signaling chain that acts as the cell’s main quality-control gate before DNA replication.

Rb works by physically binding to a group of transcription factors called E2F. When Rb sits on E2F, it silences a large number of genes needed for cell cycle progression. The cell can only move forward when cyclin-CDK complexes phosphorylate Rb, causing it to release E2F, which then switches on those genes. This is the normal “go” signal.

P53 can override that signal. When something goes wrong, such as DNA damage or viral infection, p53 becomes active and turns on the gene for p21. Rising p21 levels inhibit the cyclin-CDK complexes that would normally phosphorylate Rb. With Rb locked onto E2F, the genes needed for division stay silent, and the cell arrests. So p53 doesn’t directly block the cycle itself. It works indirectly, through p21, through Rb, through E2F, creating a chain of command that shuts everything down until the problem is resolved.

DNA Damage Sensors

Cells have dedicated sensor proteins that detect broken or damaged DNA and relay emergency signals to halt division. The two primary sensors are the kinases ATM and ATR. When these detect damage (double-strand breaks in the case of ATM, stalled replication forks for ATR), they activate downstream kinases called Chk1 and Chk2. These checkpoint kinases then phosphorylate targets that stabilize p53 and degrade proteins needed for CDK activation, enforcing arrest at both the G1/S and G2/M boundaries. This gives the cell time to repair its DNA before copying or dividing it, preventing mutations from being passed to daughter cells.

Protein Destruction: SCF and APC/C

The cell cycle depends not just on building proteins at the right time but on destroying them at the right time. Two protein-destruction machines handle this: the SCF complex and the APC/C (anaphase-promoting complex).

Both work through a process called ubiquitination. A small protein called ubiquitin gets attached to the target protein through a three-enzyme cascade (E1, E2, and E3). Once a protein is tagged with a chain of ubiquitin molecules, the cell’s recycling machinery (the proteasome) recognizes and breaks it apart. SCF and APC/C serve as the E3 enzymes in this process, the ones that select which proteins get tagged.

The SCF complex operates primarily in G1 and S phase. It’s built from a constant scaffold of three proteins plus a variable “F-box” subunit that determines which target gets destroyed. Different F-box proteins recognize different substrates, giving the SCF complex versatility. It’s responsible for degrading CKIs like p27 when the cell is ready to move forward, and for eliminating cyclins whose job is done.

The APC/C takes over during mitosis and G1. It requires co-activator proteins to function: Cdc20 activates it during mitosis, while Cdh1 keeps it active through G1. With Cdc20, the APC/C destroys securin, a protein that prevents chromosomes from separating. Once securin is gone, the paired chromosomes split apart, triggering anaphase. The APC/C also destroys cyclin A during metaphase and cyclin B at the metaphase-to-anaphase transition. Without cyclin B destruction, CDK1 stays active and the cell cannot exit mitosis. Experiments with non-degradable cyclin B show that cells get stuck in a metaphase-like state where chromosome separation, cell division, and DNA re-licensing all fail.

With Cdh1 active in G1, the APC/C keeps CDK activity low, maintaining a stable gap phase until the next round of growth signals arrives.

Nutrient and Energy Sensing

Even with growth factor signals present, a cell won’t divide if it lacks the raw materials and energy to do so. Two key proteins sense the cell’s metabolic state and feed that information into the cycle.

mTOR (specifically the mTORC1 complex) acts as a nutrient sensor. When amino acids, glucose, and growth factors are abundant, mTORC1 activates and promotes protein synthesis, lipid production, and other building processes the cell needs to grow large enough to divide. Its activation depends partly on specific amino acids: leucine and arginine influence mTORC1 through a chain of regulatory protein complexes. A stress-response protein called sestrin2 normally suppresses mTORC1, but leucine binds to sestrin2 and blocks that suppression, effectively telling the cell that protein-building materials are available.

AMPK acts as the opposing signal. When cellular energy drops (low ATP levels, starvation, or low oxygen), AMPK activates and directly opposes mTORC1. It promotes recycling of cellular components through autophagy and blocks the growth signals that would push the cell toward division. The competition between mTORC1 and AMPK at the molecular level, where they phosphorylate different sites on the same target proteins, determines whether the cell grows or conserves resources. Calorie restriction tips the balance toward AMPK, while nutrient abundance tips it toward mTORC1 and proliferation.